Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • odelfour
    Junior Member
    • Oct 2008
    • 8

    #1

    Defective Sequencing Reagents to Cost Illumina up to $23M in 2009

    Hi,
    In their earning call, Illumina said they experienced issues with sequencing kits and reagents..
    How many people here did have this issue ? With which kits or reagents ?

    olivier
  • NextGenSeq
    Senior Member
    • Apr 2009
    • 482

    #2
    The rumor I heard is that Invitrogen actually makes the kits for Illumina.
    Makes one wonder if with their purchase of ABI there's some type of sabotage?
    Or maybe they have had to find another vendor to make the kits and that vendor is having trouble getting up to speed?

    Comment

    • AnthonyB
      Junior Member
      • Sep 2008
      • 8

      #3
      After skimming through the transcript of the earning report, illumina say that the problem was with their paired-end kits which manifested itself as very high read errors in the 2nd read. It was discovered in Sept. We had a PE run that was performed through a service provider fail in mid Aug in a similar way to their description so we're assuming that this may have been the problem.

      Comment

      • ScottC
        Senior Member
        • Jan 2008
        • 244

        #4
        Illumina sent out an explanation to instrument owners: It was a reagent in cluster gen kit box 2 that potentially (but not always) affects lot numbers 4834547 to 4958646.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
          by SEQadmin2




          NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
          10-30-2026, 06:46 AM
        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-28-2026, 09:57 AM
        0 responses
        33 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-28-2026, 09:51 AM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        71 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        48 views
        0 reactions
        Last Post SEQadmin2  
        Working...